307 related articles for article (PubMed ID: 34563499)
1. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
[TBL] [Abstract][Full Text] [Related]
2. Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study.
Cusimano MC; Chiu M; Ferguson SE; Moineddin R; Aktar S; Liu N; Baxter NN
BMJ; 2021 Dec; 375():e067528. PubMed ID: 34880044
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk after hysterectomy with and without salpingo-oophorectomy for benign indications.
Chow S; Raine-Bennett T; Samant ND; Postlethwaite DA; Holzapfel M
Am J Obstet Gynecol; 2020 Dec; 223(6):900.e1-900.e7. PubMed ID: 32585221
[TBL] [Abstract][Full Text] [Related]
4. Practice variation in bilateral salpingo-oophorectomy at benign abdominal hysterectomy: a population-based study.
Cusimano MC; Moineddin R; Chiu M; Ferguson SE; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2021 Jun; 224(6):585.e1-585.e30. PubMed ID: 33359174
[TBL] [Abstract][Full Text] [Related]
5. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
[TBL] [Abstract][Full Text] [Related]
6. Risk-reducing Bilateral Salpingo-oophorectomy: Assessing the Incidence of Occult Ovarian Cancer and Surgeon Adherence to Recommended Practices.
Newcomb LK; Toal CT; Rindos NB; Wang L; Mansuria SM
J Minim Invasive Gynecol; 2020; 27(7):1511-1515. PubMed ID: 31927044
[TBL] [Abstract][Full Text] [Related]
7. Bilateral salpingo-oophorectomy at the time of benign hysterectomy among females with disabilities: a population-based cross-sectional study.
Scime NV; Brown HK; Metcalfe A; Simpson AN; Brennand EA
Am J Obstet Gynecol; 2023 Dec; 229(6):658.e1-658.e17. PubMed ID: 37544349
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy.
Chan JK; Urban R; Capra AM; Jacoby V; Osann K; Whittemore A; Habel LA
Obstet Gynecol; 2014 Jan; 123(1):65-72. PubMed ID: 24463665
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of hysterectomy with bilateral salpingo-oophorectomy: a systematic review and meta-analysis.
Hassan H; Allen I; Sofianopoulou E; Walburga Y; Turnbull C; Eccles DM; Tischkowitz M; Pharoah P; Antoniou AC
Am J Obstet Gynecol; 2024 Jan; 230(1):44-57. PubMed ID: 37364803
[TBL] [Abstract][Full Text] [Related]
10. Short- and long-term outcomes for single-port risk-reducing salpingo-oophorectomy with and without hysterectomy for women at risk for gynecologic cancer.
Carr CE; Chambers L; Jernigan AM; Freeman L; Escobar PF; Michener CM
Int J Gynecol Cancer; 2021 Feb; 31(2):215-221. PubMed ID: 32948638
[TBL] [Abstract][Full Text] [Related]
11. Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
Assaf W; Andraous M; Lavie O; Segev Y
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():48-54. PubMed ID: 35279641
[TBL] [Abstract][Full Text] [Related]
12. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
Mai PL; Miller A; Black A; Falk RT; Boggess JF; Tucker K; Stuckey AR; Rodriguez GC; Wong C; Amatruda TT; Wilkinson KJ; Modesitt SC; Yamada SD; Bixel KL; Glaser GE; Rose PG; Greene MH; Sherman ME
Am J Obstet Gynecol; 2022 Jul; 227(1):61.e1-61.e18. PubMed ID: 35216968
[TBL] [Abstract][Full Text] [Related]
13. The risk of stroke after bilateral salpingo-oophorectomy at hysterectomy for benign diseases: A nationwide cohort study.
Lai JC; Chou YJ; Huang N; Chen HH; Wang KL; Wang CW; Shen IH; Chang HC
Maturitas; 2018 Aug; 114():27-33. PubMed ID: 29907243
[TBL] [Abstract][Full Text] [Related]
14. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer.
Berek JS; Chalas E; Edelson M; Moore DH; Burke WM; Cliby WA; Berchuck A;
Obstet Gynecol; 2010 Sep; 116(3):733-743. PubMed ID: 20733460
[TBL] [Abstract][Full Text] [Related]
16. Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006.
Asante A; Whiteman MK; Kulkarni A; Cox S; Marchbanks PA; Jamieson DJ
Obstet Gynecol; 2010 Nov; 116(5):1088-95. PubMed ID: 20966693
[TBL] [Abstract][Full Text] [Related]
17. Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists.
Blustein P; Werner SR; Uppalapati P; Leung TM; Husk GA; Pereira EB; Whyte JS; Villella JA
Am J Obstet Gynecol; 2023 Sep; 229(3):280.e1-280.e8. PubMed ID: 37308046
[TBL] [Abstract][Full Text] [Related]
18. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
[TBL] [Abstract][Full Text] [Related]
19. Hysterectomy status and all-cause mortality in a 21-year Australian population-based cohort study.
Wilson LF; Pandeya N; Byles J; Mishra GD
Am J Obstet Gynecol; 2019 Jan; 220(1):83.e1-83.e11. PubMed ID: 30312584
[TBL] [Abstract][Full Text] [Related]
20. Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.
Smith MJ; Gerber D; Olsen A; Khouri OR; Wang Y; Liu M; Smith J; Pothuri B
Am J Obstet Gynecol; 2021 Nov; 225(5):508.e1-508.e10. PubMed ID: 34171390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]